ASR hip implants have been rejected in the U.S., but are still sold overseas

By

    ASR hip implants, rejected in U.S., still sold overseas  (MassDevice)
A new report reveals that Johnson & Johnson continued overseas sales of its metal-on-metal ASR hip implants after the FDA rejected them for the U.S. market.
Johnson & Johnson's metal-on-metal hip implants stayed on the market in Europe and other countries after they were rejected for the U.S. market, according to a report from the New York Times.
The implants were sold to patients overseas for a year after they were prohibited for U.S. patients, until they were recalled in August 2010 amid concerns about high fai...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.